Mineralys Therapeutics has reported Phase 3 data showing lorundrostat reduced [...]

Tango Therapeutics has reported an 82% objective response rate with [...]

Sagimet Biosciences is preparing to begin screening patients for its [...]

Grifols has completed patient follow-up in its Phase 3 SPARTA [...]

Alto Neuroscience has raised $100 million through an underwritten registered [...]

Erasca has reported updated preliminary Phase 1 data for its [...]

Compass Pathways has reported positive six-month results from its second [...]

Telix Pharmaceuticals has received FDA agreement on the protocol and [...]

Atsena Therapeutics has dosed the first patient in the Phase [...]

AstraZeneca’s Imfinzi (durvalumab) has been recommended by NICE for use [...]